DSOG Guideline Bulletin: Retained Products of Conception in Postpartum Women

The aim of this guideline was to update an existing guideline from 2014. Retained products of conception (RPOC) is a recognized cause of secondary postpartum hemorrhage (PPH), affecting 1-6% of postpartum women. Despite its clinical significance, evidence on the diagnosis and management of RPOC remains limited. This guideline provides recommendations for both hemodynamically stable and unstable patients. Seven research questions were formulated to evaluate diagnostic methods of RPOC and compare different treatment modalities. The level of evidence was graded according to the Oxford Centre for Evidence-based Medicine Levels of Evidence depending on the study quality. According to the literature diagnosis of RPOC remains challenging, as RPOC can mimic normal postpartum uterine changes on ultrasound. Ultrasound, particularly with Doppler flow, plays a valuable role in diagnosis of RPOC, and findings such as a midline echo ≥10 mm or an intracavitary hyperechogenic mass should be correlated with clinical symptoms to guide management. Management options include watchful waiting and surgical intervention. Medical management has shown limited success, often necessitating secondary surgical treatment. Watchful waiting may be considered in hemodynamically stable patients regardless of ultrasonographic findings, although comparative data with active treatment is inconclusive. Surgical treatments include dilation and curettage (D&C) or hysteroscopic resection. Though widely used, D&C is a blind procedure with risks such as uterine perforation and intrauterine adhesions, potentially affecting future fertility. Hysteroscopy, offering direct visualization and targeted removal, minimizes endometrial damage and adhesions and is increasingly preferred where expertise and resources are available. Hemodynamically unstable patients with ongoing severe bleeding may undergo D&C, preferably guided by ultrasound. Hysteroscopy within the first postpartum weeks, especially in the presence of ongoing heavy bleeding, can be technically difficult to conduct, but is the preferred choice when possible. The level of evidence across studies ranged from 2b to 4, emphasizing the need for further research in this field.

Authors

Institutions

Publication Details

Journal
Danish Journal of Obstetrics and Gynaecology
Published
2025-06-02
DOI
https://doi.org/10.56182/6gvh5495
Primary Topic
Reproductive Health and Contraception
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DSOG Guideline Bulletin: Retained Products of Conception in Postpartum Women

Morten Hedegaard, Arushma Imran Naqash, Hellen McKinnon Edwards, Simon Foged Victor et al.
Danish Journal of Obstetrics and Gynaecology
Reproductive Health and Contraception
article

DSOG Guideline Bulletin: Retained Products of Conception in Postpartum Women

Morten Hedegaard, Arushma Imran Naqash, Hellen McKinnon Edwards, Simon Foged Victor, Hevy Sadraddin Gibrael, Christer Grönlund, Michael Wegmann, Claus Otto Lund, M Nielsen-Breining
article en

Abstract

The aim of this guideline was to update an existing guideline from 2014. Retained products of conception (RPOC) is a recognized cause of secondary postpartum hemorrhage (PPH), affecting 1-6% of postpartum women. Despite its clinical significance, evidence on the diagnosis and management of RPOC remains limited. This guideline provides recommendations for both hemodynamically stable and unstable patients. Seven research questions were formulated to evaluate diagnostic methods of RPOC and compare different treatment modalities. The level of evidence was graded according to the Oxford Centre for Evidence-based Medicine Levels of Evidence depending on the study quality. According to the literature diagnosis of RPOC remains challenging, as RPOC can mimic normal postpartum uterine changes on ultrasound. Ultrasound, particularly with Doppler flow, plays a valuable role in diagnosis of RPOC, and findings such as a midline echo ≥10 mm or an intracavitary hyperechogenic mass should be correlated with clinical symptoms to guide management. Management options include watchful waiting and surgical intervention. Medical management has shown limited success, often necessitating secondary surgical treatment. Watchful waiting may be considered in hemodynamically stable patients regardless of ultrasonographic findings, although comparative data with active treatment is inconclusive. Surgical treatments include dilation and curettage (D&C) or hysteroscopic resection. Though widely used, D&C is a blind procedure with risks such as uterine perforation and intrauterine adhesions, potentially affecting future fertility. Hysteroscopy, offering direct visualization and targeted removal, minimizes endometrial damage and adhesions and is increasingly preferred where expertise and resources are available. Hemodynamically unstable patients with ongoing severe bleeding may undergo D&C, preferably guided by ultrasound. Hysteroscopy within the first postpartum weeks, especially in the presence of ongoing heavy bleeding, can be technically difficult to conduct, but is the preferred choice when possible. The level of evidence across studies ranged from 2b to 4, emphasizing the need for further research in this field.

Danish Journal of Obstetrics and GynaecologyVol. 3(1)
Herlev Hospital (DK), Hvidovre Hospital (DK), Rigshospitalet (DK), Northern Hospital (AU), Zealand University Hospital (DK), Slagelse Hospital (DK)
Openalex Percentile: Top 83%
Reproductive Health and Contraception
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.